CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock News

NASDAQ:CNTB - US2075231017 - ADR

2.11 USD

+0.05 (+2.43%)

Last: 9/2/2025, 8:00:00 PM

2.2 USD

+0.09 (+4.27%)

After Hours: 9/2/2025, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CNTB Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in September

7 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in September

20 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide

21 days ago - By: The Motley Fool

Connect Biopharma Posts Q2 Revenue Drop

21 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

21 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors

a month ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors

a month ago - By: Benzinga - Mentions: ACHC REPL MEDP IOVA ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

a month ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

a month ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

2 months ago - By: Benzinga - Mentions: CALC KPTI CAPR ATHE ...

12 Health Care Stocks Moving In Friday's Intraday Session

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in June

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in June

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

5 months ago - By: ACCESS Newswire - Mentions: BFRG

Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma